Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin

Sacramento Pediatric Gastroenterology · NCT02137668

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 0 mo–40 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
200
US sites recruiting
1
Study start
July 2010
Record last updated
November 15, 2016

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is twofold. First, is to determine whether vancomycin is effective in the early treatment of Biliary Atresia (BA) and Primary Sclerosing Cholangitis (PSC), and if so, by what mechanism. Secondly, to characterize human intestinal microbial communities and their interactions with the host.

Being studied: Oral Vancomycin

Conditions: Primary Sclerosing Cholangitis; Biliary Atresia

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Persons who have primary sclerosing cholangitis, biliary atresia, a chronic intestinal disorder or who are undergoing upper or lower endoscopy.
  • Persons who have primary sclerosing cholangitis or biliary atresia who are good candidates for vancomycin therapy.

Exclusion Criteria

  • Patients that have taken antibiotics and/or immunomodulators within the last 3 months will be excluded as this will alter the original bacterial flora.
  • Females who are pregnant may not participate.

Recruiting US locations

  • Sacramento Pediatric Gastroenterology

    Sacramento, CA 95841

    Site contact: Yinka Davies, MD · 916-332-1244

Treating Primary Sclerosing Cholangitis and Biliary Atresia With… (NCT02137668) | Bored Studies